The MLSC on May 29, 2013, announced the awarding of $2 million in loans to two early-stage life sciences companies. The MLSC’s Accelerator Program provides loans of up to $1 million to early-stage companies engaged in life sciences research and development, commercialization, and manufacturing. The MLSC’s Board of Directors approved the seventh round of Accelerator loans today.
The companies that were authorized to receive Accelerator loans (pending additional due diligence by MLSC staff) are Cytrellis Biosystems, of Boston, and Lumicell Diagnostics, of Wellesley, Mass.